dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.

Sunitinib: prices and alternatives

Sunitinib is a multi-targeted kinase inhibitor indicated for gastrointestinal stromal tumor (GIST) after imatinib failure, advanced renal cell carcinoma (RCC), adjuvant treatment of high-risk RCC following nephrectomy, and progressive well-differentiated pancreatic neuroendocrine tumors (pNET).

4 products with this active ingredient from 2 manufacturers. Official prices from 3137 to 24480 EGP.

Every box with this active ingredient, cheapest first.

Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.